Raises Concerns About Board's "Objectivity and Independence" and Questions its "Ability to Perform its Proper Oversight Role"
Recognizes Ceragon's track record of underperformance and questions standalone strategy
Read more at prnewswire.comhello world
Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.
